All In MedTech

FDA Clearance Tracker · P950032-S028

APILGRAF(GRAFTSKIN)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 17, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 17, 2002

Approved

Time to decision

85 days

Received Oct 24, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P950032-S028
Device name
APILGRAF(GRAFTSKIN)
Applicant location
Canton, MA
Received
Oct 24, 2001
Decided
Jan 17, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Other
Original approval
P950032

Device type

Device class
Class III

Every decision under product code MGR

FDA's approval statement

As written in FDA's record.

APPROVAL FOR REMOVAL OF THE CMV IGG ANTIBODY TEST FROM THE ANTEPARTUM MATERNAL DONOR SERUM TESTING PANEL, WHILE CONTINUING TO TEST THE MATERNAL DONOR SERA FOR CMV IGM ANTIBODIES AND THE MASTER CELL BANK FOR CMV VIA PCR.

Source documents

Other decisions for Organogenesis, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.